Loss-of-function mutations of SCN9A were associated with congenital insensitivity to pain [17], while gain-of-function mutations of this gene were associated with neuropathic pain syndromes, including erythromelalgia, paroxysmal extreme pain disorder, and small-fiber neuropathy [18,19]. This evidence concerns the gene SCN9A and erythromelalgia.